Simone C Oostindie

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Simone C Oostindie, Derek A Rinaldi, Gijs G Zom, Michael J Wester, Desiree Paulet, Kusai Al-Tamimi, Els van der Meijden, Jennifer R Scheick, Tessa Wilpshaar, Bart de Jong, Marloes Hoff-van den Broek, Rachel M Grattan, Janita J Oosterhoff, Julie Vignau, Sandra Verploegen, Peter Boross, Frank J Beurskens, Diane S Lidke, Janine Schuurman, Rob N de Jong
Logic-gated antibody pairs that selectively act on cells co-expressing two antigens. Nature biotechnology 40 (10) (2022)
Simone C Oostindie, Greg A Lazar, Janine Schuurman, Paul W H I Parren
Avidity in antibody effector functions and biotherapeutic drug design. Nature reviews. Drug discovery 21 (10) (2022)
Simone C Oostindie, Hilma J van der Horst, Laurens P Kil, Kristin Strumane, Marije B Overdijk, Edward N van den Brink, Jeroen H N van den Brakel, Hendrik J Rademaker, Berris van Kessel, Juliette van den Noort, Martine E D Chamuleau, Tuna Mutis, Margaret A Lindorfer, Ronald P Taylor, Janine Schuurman, Paul W H I Parren, Frank J Beurskens, Esther C W Breij
DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies. Blood cancer journal 10 (3) (2020)

Simone C Oostindie.css-eqlu8i{font-size:small;padding-left:4px;}